ABREZEKIMAB
UNII 7V0TA49ZVC

Substance Identification & Data

This profile provides standardized clinical and technical data for Abrezekimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7V0TA49ZVC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2043952-59-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
7V0TA49ZVC
CAS Registry Number
2043952-59-4
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
ABREZEKIMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C167050
National Cancer Institute reference terminology for clinical and research data.
INN ID
10745
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Abrezekimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ABREZEKIMAB

Common Names & Synonyms

ABREZEKIMAB [INN]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTERLEUKIN 13) (HUMANIZED MONOCLONAL CDP7766 .GAMMA.1-CHAIN FAB FRAGMENT), DISULFIDE WITH HUMANIZED MONOCLONAL CDP7766 .KAPPA.-CHAIN

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus